Fractures in kidney transplant recipients : a comparative study between England and New York State by Arnold, Julia et al.
  
 
 
 
warwick.ac.uk/lib-publications 
 
 
 
 
 
Original citation: 
Arnold, Julia, Mytton, Jemma, Evison, Felicity, Gill, Paramjit, Cockwell, Paul, Sharif, Adnan 
and Ferro, Charles J. (2017) Fractures in kidney transplant recipients : a comparative study 
between England and New York State. Experimental and Clinical Transplantation . 
doi:10.6002/ect.2017.0016 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/87581        
 
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work by researchers of the 
University of Warwick available open access under the following conditions. Copyright © 
and all moral rights to the version of the paper presented here belong to the individual 
author(s) and/or other copyright owners. To the extent reasonable and practicable the 
material made available in WRAP has been checked for eligibility before being made 
available. 
 
Copies of full items can be used for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge. Provided that the authors, title and full 
bibliographic details are credited, a hyperlink and/or URL is given for the original metadata 
page and the content is not changed in any way. 
 
Publisher’s statement: 
Published version: http://doi.org/10.6002/ect.2017.0016  
 
A note on versions: 
The version presented here may differ from the published version or, version of record, if 
you wish to cite this item you are advised to consult the publisher’s version. Please see the 
‘permanent WRAP URL’ above for details on accessing the published version and note that 
access may require a subscription. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk 
 
 1 
Fractures in Kidney Transplant Recipients: A comparative study between England and 
New York State 
Running Head: Fractures after Kidney Transplantation 
 
Julia Arnold MBBS1, Jemma Mytton BSc2, Felicity Evison BSc2, Paramjit S Gill MD3, Paul 
Cockwell PhD1, Adnan Sharif MD1, Charles J Ferro MD1 
 
1Department of Nephrology, University Hospitals Birmingham NHS Foundation Trust and 
Department of Renal Medicine, University of Birmingham 
2Department of Informatics, University Hospitals Birmingham NHS Foundation Trust. 
3Primary Care Clinical Sciences, Institute of Applied Health Research, University of 
Birmingham 
  
Address for correspondence: Dr Charles J Ferro, Department of Nephrology, Queen 
Elizabeth Hospital, Birmingham, B15 2WB, UK. 
 
Email: charles.ferro@uhb.nhs.uk  Tel: +44 121 3715859 Fax: +44 121 3715858 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
Abstract 
 
Objectives 
Fractures are associated with high morbidity and are a major concern to kidney transplant 
recipients. There has not been any comparative analysis conducted between countries in the 
contemporary era to inform future international prevention trials.  
Materials and Methods 
Data were obtained from the Hospital Episode Statistics and the Statewide Planning and 
Research Cooperative databases on all adult kidney transplants performed in England and 
New York State respectively (2003-2013) and on post-transplant fracture-related 
hospitalization (2003-2014).  
Results 
In total, 18,493 English and 11,602 New York State kidney transplant recipients were 
included. Overall, 637 (3.4%) English and 398 (3.4%) New York State recipients sustained a 
fracture giving an unadjusted event rate of 7.0 and 5.9 per 1000 years respectively (P=0.948). 
A total of 147 (0.8%) English and 101 (0.9%) New York State recipients sustained a hip 
fracture, giving an unadjusted event rate of 1.6 and 1.5 per 1000 years respectively 
(P=0.480). There were no differences in the cumulative incidence of all fractures or hip 
fractures. One-year mortality after any fracture (9% and 11%) or after a hip fracture (15% 
and 17%) was not different between cohorts. 
Conclusions 
Contemporaneous English and New York State kidney transplant recipients have very similar 
fracture rates and mortality post-fracture. 
 
Key words: Kidney transplant, fracture, mortality, epidemiology 
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Introduction 
Bone disease is a major fear for kidney transplant recipients, ranking high on a list of patient 
concerns[1]. Kidney transplant recipients have a higher fracture risk than the general 
population[2-10]. This increased risk has been attributed to changes in bone mineral 
metabolism as a consequence of impaired renal function and the prolonged use of high dose 
glucocorticoids. However, most studies were done before 2000[11], have had only short-term 
follow-up and demonstrate large inter-study variability in fracture rates[11]. 
 
Hip fractures are common, costly, require hospitalization, and are associated with poor 
outcomes[12, 13]. In the general population mortality rates after hip fracture have changed 
little over the past 30 years despite surgical and medical advances[14-16]. Hip fracture rates 
vary widely across countries and are higher in the United States of America (USA) than in 
Canada; with both these countries reporting higher fracture rates than England[13, 17-19]. 
Ethnicity is also associated with hip fractures; people of black ethnicity consistently sustain 
lower fracture rates than whites[18]. 
 
Recent studies from England and Ontario Province, Canada in contemporary cohorts have 
shown that hip fracture rates in kidney transplant recipients are lower than have been 
historically reported[20, 21]. These studies suggest that any future trial on fracture prevention 
would need to be international because of the low overall numbers involved.  
 
A better understanding of fracture incidence in kidney transplant recipients and comparisons 
between countries remains important for estimating sample size requirements for potential 
future fracture prevention trials and gaining a better understanding of whether systematic 
differences in the population demographics and healthcare systems and whether the 
background rate of fracture in the general population may be contributing to fracture rates 
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and post-fracture outcomes, including mortality. To our knowledge, no comparative analysis 
of fracture rates has ever been conducted between countries in the contemporary era. We 
therefore conducted this study to provide estimates of incidence rates of all fractures and hip 
fractures requiring hospitalization in all adult kidney transplant recipients from England and 
New York State (NYS), USA. We also examined 1-year mortality rates post-fracture and 
causes of death. 
 
Materials and Methods 
Study Population 
We performed a retrospective cohort study of all kidney-alone transplants performed in 
adults (aged greater than 18 at time of transplantation) in England and NYS between January 
2003 and December 2013. Patients were followed up until December 2014 allowing all 
patients the potential to have at least 1 year of follow-up. We collected patient demographics 
that included age, gender, ethnicity, and medical co-morbidities at the time of transplantation.  
 
Data Sources 
For patients transplanted in England, data was obtained from Hospital Episodes Statistics 
(HES), an administrative database containing all admissions to National Health Service 
hospitals in England. Data was extracted utilizing codes on procedural classifications (Office 
of Population Censuses and Surveys Classification of Interventions and Procedures, 4th 
revision (OPCS-4) and medical classifications (World Health Organization International 
Classification of Diseases, 10th revision (ICD-10)).[20] Mortality (including cause of death) 
was determined by linkage to the Office of National Statistics (ONS)[20]. 
 
For patients transplanted in New York State, data was extracted from the Statewide Planning 
and Research Cooperative (SPARCS), a comprehensive all-payer administrative database 
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with information on all admissions to non-federal hospitals in New York State. Data was 
extracted utilizing codes on medical classifications (World Health Organization International 
Classification of Diseases, 9th revision (ICD-9)) and procedural classifications (ICD-9 
Procedure Codes) and medical classifications.[16] Mortality was determined using a linkage 
to the NYS Department of Vital Statistics and New York City Department of Vital 
Statistics[16]. 
 
Both HES and SPARCS databases have previously been used to study the incidence of 
fractures[16, 20, 22, 23]. Only pseudoanonymized data was available for analysis. As such, 
this study did not require institutional review board approval. 
 
Outcomes 
Patients who after renal transplantation were readmitted to hospital in England with a fracture 
ICD-10 code (S02, S12, S22, S32, S42, S52, S62, S72, S82, S92, T02, T07, T10, T12) and in 
New York State with a fracture ICD-9 code (800-829) were flagged. Hip fractures were 
defined as ICD-10 codes S72.0-S72.2 and ICD-9 code 820. Data on fractures occurring 
before transplantation were also collected and analyzed as a potential risk factor for post-
transplantation fracture. Mortality within 1 year of a fracture was also collected. 
 
Statistical Analyses 
Differences between groups were compared using chi-square tests for categorical variables 
and Mann-Whitney tests for continuous variables. We defined 1-year, 3-year, 5-year and 10-
year cumulative incidence of fracture as the proportion of kidney transplant recipients who 
sustained a fracture within the respective period of follow-up; no fracture could occur in 
follow-up if the recipient died before fracture. We calculated the 1-year, 3-year, 5-year and 
10-year incidence rates of fracture (defined as the rate per 1000 patient-years of follow-up; 
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censoring at the time of death or fracture in follow-up). Results are presented for the entire 
cohorts and by gender (male versus female) and age (<50 versus ≥ 50 years) at the time of 
transplantation. The age cut-off was chosen for several reasons, namely that the median age 
of participants was 50 years, the average age of menopause is approximately 50 years[24, 25] 
and fracture risk increases after the menopause[26], and previous research has found kidney 
transplant recipients older than 50 years to have an increased fracture risk[10]. Our analyses 
were also performed to be as much as possible directly comparable to a recent analysis 
performed on a contemporaneous cohort of kidney transplant recipients from Ontario, 
Canada[21]. 
 
Time-to-fracture outcomes were analyzed with the Cox’s proportional hazards model and the 
log-rank test. All variables used in the analyses had <5% of the values missing and were 
therefore treated as missing at random with case-wise deletion. Results are presented as 
Hazard Ratios (HR) with 95% confidence intervals (95% CI). Mortality in the year following 
a fracture was analyzed using logistic regression analysis. Variables included in the models 
were age, gender, ethnicity, history of fracture before transplantation and available medical 
comorbidities, including history of myocardial infarction, peripheral vascular disease, 
cerebrovascular disease, congestive cardiac failure, pulmonary disease, cancer, liver disease 
and diabetes mellitus. Results are presented as the Odds Ratio (OR) with 95% CI. Analyses 
were performed using Stata statistical software (V14, Statacorp, LP, Texas, USA). A P value 
of <0.05 was considered statistically significant. 
 
Results 
We studied 18,493 adults from England and 11,602 adults from NYS who received a kidney 
transplant from January 2003 to December 2013. Recipients were followed up until 
December 2014, giving a total of 90,655 patient-years (median 5 years, range 0-12 years) 
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follow-up for English recipients and 67,743 patient-years (median 6 years, range 0-12 years) 
follow-up for NYS recipients. The baseline characteristics of both cohorts are described in 
Table 1. Recipients from NYS were older (51 (interquartile range (IQR) 41-61 years) vs. 48 
(IQR 38-58) years; P<0.001), more likely to be of black ethnicity (23% vs. 7%; P<0.001) and 
more likely to be diabetic (38% vs. 15%; P<0.001). Recipients from NYS also had increased 
pre-transplant cardiovascular morbidity than English recipients with a higher incidence of 
myocardial infarction, heart failure, peripheral vascular disease and cerebrovascular disease 
(P<0.001 for all). English recipients were more likely to have been diagnosed with 
pulmonary disease than NYS recipients (12% vs. 0.6%: P<0.001) and more likely to have 
sustained a fracture before transplantation (3.1% vs. 2.5%; P=0.002). 
 
All fracture risk 
In total 637 (3.4%) English kidney transplant recipients sustained any fracture during the 
follow-up period with 34 (0.2%) recipients sustaining two fractures, 9 (0.1%) recipients 
sustaining three and 8 (0.04%) recipients sustaining four or more fractures. In total 398 
(3.4%) NYS kidney transplant recipients sustained any fracture during the follow-up period 
with 76 (0.7%) recipients subsequently sustaining two fractures, 10 (0.1%) recipients 
sustaining three and 8 (0.1%) recipients sustaining four or more fractures. There were no 
differences in the proportions of recipients in both cohorts sustaining any fracture or more 
than one fracture. The unadjusted event rate for any fracture was 7.0 per 1000 patient years 
for the English cohort and 5.9 per 1000 years for the NYS cohort (P=0.948). Overall, there 
were no differences between the groups in the proportion of recipients admitted with lower 
limb, upper limb, trunk or skull fractures.  
 
The 1-year, 3-year, 5-year and 10-year cumulative incidence and incidence rate of any 
fracture are presented in Table 2 and according to age and gender in Supplementary Table 1. 
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For both English and NYS recipients, women over 50 had the highest rates of fracture at all 
time-points. There were no differences between the English and NYS cohorts in the 
cumulative incidence or incidence rates at any time point when taken as a whole (Table 2; 
Figure 1) or in any of the sub-groups (Supplementary Table 1).  
 
Parameters associated with sustaining any fracture for both English of NYS recipients are 
presented in Table 3A. Increasing age, female gender, white ethnicity, pre-transplantation 
diabetes mellitus and having sustained a fracture pre-transplant were associated with 
sustaining a fracture post-transplantation in both groups. When all recipients were combined, 
being a NYS kidney transplant recipient was not associated with an increased fracture risk 
(HR 1.03, 95% CI 0.89 – 1.18; P=0.699) compared to an English recipient. This joint 
analysis made no material difference to the relationship between the other parameters and 
fracture risk (Supplementary Table 2). 
 
Hip fracture risk 
In total 147 (0.8%) English and 101 (0.9%) NYS kidney transplant recipients sustained a hip 
fracture during the study period (P=0.480), giving a crude all fracture incidence rate of 1.6 
per 1000 patient years and 1.5 per 1000 patient years respectively. The 1-year, 3-year, 5-year 
and 10-year cumulative incidence and incidence rate of hip fracture are presented in Table 4 
and according to age and gender in Supplementary Table 3. For both the English and NYS 
cohorts, women over 50 years of age had the highest rates of fracture at all time points. There 
were no differences between the English and NYS cohorts in the cumulative incidence or 
incidence rates at any time point when taken as a whole (Table 4; Figure 1) or in any of the 
sub-groups (Supplementary Table 3). The 10-year cumulative incidence rate for women over 
50 was 3.26% (95% CI 1.70-6.2) for English recipients and 2.62% (95% CI 1.37-4.97) for 
NYS recipients, with no difference between the groups (P=0.210). 
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Variables associated with sustaining a hip fracture in both English and NYS cohorts are 
presented in Table 3B. Factors associated with hip fracture were similar to those associated 
with sustaining any fracture, except that black ethnicity was not associated with a lower rate 
of fracture in English recipients and having sustained a fracture pre-transplantation was not 
associated with a greater risk of hip fracture in NYS recipients. When both cohorts were 
combined, being a NYS kidney transplant recipient was not associated with an increased hip 
fracture risk (HR 0.90, 95% CI 0.67-1.20; P=0.473: Supplementary Table 4) compared to an 
English patient. In this combined analysis black ethnicity was associated with a reduced hip 
fracture risk (HR 0.42, 95% CI 0.25-0.71; P=0.001) and having sustained a fracture before 
transplantation was associated with an increased hip fracture risk (HR 2.48, 95% CI 1.49-
4.14; P<0.001). 
 
One-year mortality post fracture 
Within 1 year of sustaining any fracture 55 (9%) English and 43 (11%) NYS recipients had 
died (P=0.246). Within 1 year of sustaining a hip fracture 22 (15%) English and 17 (17%) 
NYS recipients had died (P=0.692).  In both univariable and multivariable analyses, being an 
English or NYS kidney transplant recipient was not associated with an increased 1-year 
mortality after any fracture (OR 1.11, 95% CI 0.69-1.79; P=0.655: Supplementary Table 5) 
or hip fracture (OR 0.92, 95% CI 0.47-1.82; P=0.819: Supplementary Table 6).  
 
Causes of death were only available for the English kidney transplant recipients; of the 55 
deceased no cause of death was reported more than 5 times, which prevents us from showing 
the data for reasons of privacy. 
 
Discussion 
 10 
We have found that all fracture rates requiring hospitalization and hip fracture rates in kidney 
transplant recipients with different baseline demographics from two very different health care 
systems, England and NYS, are not different at 1, 3, 5 and 10 years post-transplantation. 
Furthermore, we have shown that the 1-year mortality after any fracture or hip fracture is the 
same across both cohorts. These findings have important implications for future studies 
aimed at reducing the rate of fractures in kidney transplant recipients, as well as reducing the 
high mortality associated with fractures.  
 
Our finding that fracture rates requiring hospitalization, and especially hip fracture rates, are 
the same in England as in NYS is perhaps unexpected given the differences in demographics 
between the two populations. Recipients from NYS were older and a larger proportion were 
diabetic than English recipients. These demographics are consistent with the known 
differences in the end-stage renal disease populations between England and the US[27, 28]. 
However, whereas black ethnicity is known to be associated with a significantly lower rate of 
fractures compared to white ethnicity[18, 20], older age[29-32] and being diabetic[20, 33] are 
associated with an increased risk. Thus it appears that these risk factors potentially cancel 
each other out across the overall population. 
 
A recent study from Ontario reported fracture rates in kidney transplant recipients from 
Ontario over a similar time period has reported similar fracture rates to our study[21]. They 
reported a 3-year cumulative hip fracture rate of 0.4% (95% CI 0.3-0.7), which is identical to 
the rates we found in both the English and NYS recipients of 0.4% with very similar 
confidence intervals (95% CI 0.3-0.6) for both. Furthermore, they reported a 10-year 
cumulative incidence rate for hip fractures of 1.7% (95% CI 1.2-2.3). Although the rates we 
report for England and NYS were slightly lower at 1.4% (95% CI 1.0-2.0) and 1.4% (0.9-2.0) 
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respectively, the confidence intervals are wide, given the much lower numbers of patients 
with this length of follow-up, and overlap considerably.  
 
Thus it appears that the rates of hip fractures in kidney transplant recipients are virtually 
identical in three distinct populations England, NYS and Ontario. This is perhaps 
unanticipated given that hip fracture rates vary greatly in the general population across 
countries. The US population has significantly higher rates than the Canadian population, 
which in turn has a higher rate than that reported in England[13, 17-19]. These differences 
are considerable; a recent study reported that Canadian women had a 30% lower rate of hip 
fractures compared to US women[19]. Our finding of virtually identical hip fracture rates in 
kidney transplant recipients from England and NYS, which are effectively the same as those 
seen in Ontario, suggests a commonality of risk factors in these groups that do not necessarily 
reflect the underlying prevalence of risk factors in their respective general populations.  
 
Our study is also consistent with the recently published report on kidney transplant recipients 
from Ontario[21] in that only women aged over 50 years were a high risk group for fracture 
as defined by a hip fracture rate greater than 3% at 10 years[26, 34]. This patient group 
should be considered a priority for measures designed to prevent fractures post-
transplantation or indeed as the preferred high-risk group for a future study of fracture 
prevention. However, it should be noted that in both our study and in the Canadian study, the 
total at risk population was very low (n=696 and n=354 respectively). 
 
Several studies have documented a high mortality rate after hip fractures in the general 
population[35-39]. In our previous study we reported a mortality of 16% within 1 year of a 
hip fracture in an English kidney transplant recipient population,[20] which was higher than 
previously reported rates from the US[4, 40]. This appeared to be consistent with reports that 
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mortality in the general population was also lower in the US than England[41]. Differences in 
healthcare systems between the two countries including the timing of interventions and 
length of hospital stay had been postulated to affect survival[42]. In this current study, 
however, we have found that mortality after any fracture requiring hospitalization and after a 
hip fracture in both the English and NYS recipient were very similar with no differences 
detected. 
 
Although rates of acute myocardial infarction are high post-hip fracture[43] the cause of 
mortality and associated comorbid conditions vary widely with no clear pattern in the general 
population[44]. In this study, we were only able to examine the causes of death in the English 
population (NYS data on cause of death was not available). However, like reports from the 
general population, we were unable to identify either associated comorbidities or a particular 
cause or group of causes for death, suggesting that, other than preventing the fracture in the 
first place, a wide approach is required to lower mortality. 
 
Our study has a number of strengths as well as limitations. We were able to include all 
patients transplanted in England and NYS. Loss to follow-up would only have happened if 
the recipient left the country or state. As is often done, we used administrative data to 
ascertain comorbidities despite the fact that there are problems with under-reporting of 
diagnosis codes for many conditions and this may vary systematically across healthcare 
systems[45-47]. We reported higher rates of cardiovascular co-morbidities in NYS kidney 
transplant recipients compared to their English counterparts. A significant proportion of this 
could perhaps be explained by the much higher incidence of diabetes in NYS recipients 
(entirely consistent with what is known about the US dialysis population), as well as their 
higher median age.  It may also be caused by a systematic bias in reporting, which may also 
be the most likely explanation for the higher reported rates of chronic pulmonary disease we 
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found in the English cohort. Nevertheless, the presence of these comorbidities does not 
appear to be associated with fracture incidence rates in either populations when studied 
separately or in combination. Like many other studies in this field we did not have creatinine 
values to determine the degree to which the transplant recipients had CKD. We only had 
access to recipients transplanted in NYS. Whether our results from NYS could be 
generalizable to other statewide populations in the USA is unknown. Overall, we are 
reassured of the robustness of our data given the high concordance of fracture incidence rates 
and associated mortality we found between the English and NYS recipient populations. In 
addition, our 3-year and 10-year cumulative incidence of hip fractures for both the English 
and NYS recipients are very similar to a recent report from Ontario, Canada, providing 
further substantiation to our data[21]. 
 
In conclusion, our results show comparable rates for fractures requiring hospitalization and 
for hip fractures in English and NYS kidney transplant recipients. We have also demonstrated 
a high mortality rate in both populations 1 year after a fracture requiring hospitalization and 
especially after a hip fracture. No single cause or group of causes for the excess mortality nor 
associated co-morbid conditions were identified, suggesting a wide range of measures would 
be required to reduce this mortality, other than preventing fractures in the first place.  
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Table 1: Baseline characteristics of kidney transplant recipients from England and New 
York State 
 
 England 
(n=18,493) 
New York State 
(n=11,602) 
P value 
Age (years) 48 (38-58) 51 (41-61) <0.001 
Women 7123 (39%) 4569    (39%) 0.14 
Ethnicity    
White 14508 (78%) 6202    (53%) <0.001 
Black 1215 (7%) 2660    (23%) 
Other 2770 (15%) 2740    (24%) 
Co-morbidities    
Myocardial infarction 1148 (6%) 1375     (12%) <0.001 
Cerebrovascular disease 803 (4%) 859          (7%) <0.001 
Congestive Heart Failure 924 (5%) 2587     (22%) <0.001 
Peripheral vascular disease 1020 (6%) 920          (8%) <0.001 
Diabetes mellitus 2781 (15%) 4462    (38%) <0.001 
Liver disease 86    (0.5%) 213         (2%) <0.001 
Pulmonary disease 2170 (12%) 68            (0.6%) <0.001 
Previous Cancer 696 (4%) 452          (4%) 0.56 
Previous fracture 566 (3%) 286         (2%) 0.002 
 
Data are medians (interquartile range) or n (%). 
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Table 2. One-year, three-year, five-year and ten-year cumulative incidence and 
incidence rates of all fractures requiring hospitalization in England and New York 
State* 
 
 Cumulative Incidence, %  
(95% Confidence Intervals) 
Incidence Rate per 1000 patient years    
(95% Confidence Intervals) 
 England NYS P value England NYS P value 
One-year 
(n=29,898) 
0.74%  
(0.63-0.88) 
0.66% 
(0.53-0.83) 
0.488 7.44                
(6.28-8.81) 
6.73                  
(5.38-8.42) 
0.50 
Three-year 
(n=23,729) 
1.96%       
(1.74-2.21) 
1.76%       
(1.51-2.05) 
0.265 6.62  
(5.87-7.46) 
5.93          
(5.09-6.91) 
0.27 
Five-year 
(n=17,810) 
3.16%  
(2.83-3.53) 
2.87%  
(2.51-3.28) 
0.273 6.43  
(5.75-7.19) 
5.83  
(5.10-6.67) 
0.27 
Ten-year 
(n=4,103) 
7.40%    
(6.34-8.62) 
5.94%    
(4.92-7.16) 
0.096 7.52  
(6.41-8.82) 
6.14  
(5.07-7.45) 
0.11 
 
 
*Cumulative incidence defined as the proportion of kidney transplant recipients who 
sustained any fracture within the follow-up period: no fracture could occur if the kidney 
transplant recipient died before fracture. Incidence rate defined as the rate per 1000 patient 
years of follow-up; censoring at the time of death or fracture in follow-up. 
 
NYS, New York State 
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Table 3. Adjusted associations between kidney transplant recipient demographics and co-morbidities with the cumulative incidence of 
all fractures requiring hospitalization(A) and hip fractures (B).  
A: All fractures requiring hospitalization* 
 
 
 England 
 
New York State 
Variable Hazard Ratio 
(95% Confidence Intervals) 
P value Hazard Ratio 
(95% Confidence Intervals) 
P value 
 
 
Age 
18 to 49 1  - 1  - 
50 to 69 1.46 (1.21-1.75) <0.001 1.36 (1.06-1.76) 0.02 
70 and over 2.51 (1.71-3.70) <0.001 2.07 (1.43-3.00) <0.001 
 
Gender 
Male 1 - 1 - 
Female 1.47 (1.23-1.75) <0.001 1.27 (1.01-1.59) 0.04 
 
Ethnicity 
White 1 - 1 - 
Black 0.58 (0.37-0.91) 0.019 0.63 (0.47-0.85) 0.002 
Other 0.64 (0.48-0.85) 0.003 0.67 (0.50-0.91) 0.009 
Pre-transplantation diabetes mellitus 2.16 (1.75-2.66) <0.001 1.95 (1.54-2.46) <0.001 
Previous Fractures 2.09 (1.41-3.08) <0.001 1.97 (1.18-3.29) 0.009 
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B: Hip fractures* 
 
 
*Models adjusted for; age, gender, ethnicity, history of myocardial infarction, peripheral vascular disease, cerebrovascular disease, congestive 
 England 
 
New York State 
Variable Hazard Ratio 
(95% Confidence Intervals) 
P value Hazard Ratio 
(95% Confidence Intervals) 
P value 
 
 
Age 
18 to 49 1 - 1 - 
50 to 69 4.00 (2.52-6.34) <0.001 3.28 (1.71-6.28) <0.001 
70 and over 8.95 (4.34-18.44) <0.001 7.48 (3.46-16.20) <0.001 
 
Gender 
Male 1 - 1 - 
Female 1.89 (1.28-2.78) 0.001 1.03 (0.63-1.67) 0.91 
 
Ethnicity 
White 1 - 1 - 
Black 0.70 (0.29-1.73) 0.445 0.40 (0.20-0.81) 0.01 
Other 0.27 (0.11-0.68) 0.005 0.34 (0.15-0.74) 0.007 
Pre-transplantation diabetes mellitus 2.70 (1.76-4.13) <0.001 1.73 (1.07-2.81) 0.03 
Previous Fractures 3.04 (1.52-6.09) 0.002 0.62 (0.08-4.47) 0.63 
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cardiac failure, pulmonary disease, diabetes mellitus and previous fractures. 
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Table 4. One-year, three-year, five-year and ten-year cumulative incidence and incidence rates 
of hip fractures* 
 
 Cumulative incidence, %  
(95% Confidence Intervals) 
Incidence Rate per 1000 patient years 
(95% Confidence Intervals) 
 England NYS P value England NYS P value 
One-year 
(n=29,898) 
0.23%   
(0.17-0.31) 
0.16%  
(0.10-0.25) 
0.162 2.33      
(1.72-3.15) 
1.57  
(0.99-2.49) 
0.16 
Three-year 
(n=23,729) 
0.42%  
(0.33-0.55) 
0.42%    
(0.30-0.57) 
0.899 1.43       
(1.10-1.85) 
1.39        
(1.02-1.91) 
0.91 
Five-year 
(n=17,810) 
0.67%          
(0.52-0.85) 
0.68%  
(0.51-0.89) 
0.924 1.34         
(1.05-1.71) 
1.37        
(1.04-1.80) 
0.98 
Ten-year 
(n=4,103) 
1.39%            
(0.96-2.01) 
1.62%    
(1.12-2.33) 
0.532 1.36           
(0.94-1.97) 
1.63       
(1.13-2.36) 
0.50 
 
NYS, New York State 
 
*Cumulative incidence defined as the proportion of kidney transplant recipients  
who sustained a hip fracture within the specified period of follow-up: no hip fracture could occur if 
follow-up if the kidney transplant recipient died before hip fracture. Incidence rate defined as the 
rate per 1000 patient years of follow-up; censoring at the time of death or fracture in follow-up. 
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Figure Legend 
 
Figure 1. Cumulative incidence of all fractures requiring hospitalization and hip fractures in 
adult kidney transplant recipients in England and New York State (NYS).  There were no 
differences in all fracture (P=0.257 by the log-rank test) and hip fracture (P=0.094 by the log-
rank test) rates between the two populations. 
 
 
 
